Page captured October 20, 2026. The current offer may differ from the original ad.

A creator smiles and touches her cheek in a wood-paneled interior, opening a retinal-serum testimonial. The creator testimonial links to the actual retinal-serum page. Its purple-and-yellow product presentation leads into an ingredient overview, use guidance, FAQ controls and reviews. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Zarina opens on a list of concerns a viewer recognizes (fine lines, large pores, volume loss) and turns the ad into a lesson with the line "How you use it makes all the difference." That framing gives people a reason to keep watching even if they already use a retinoid. She brings specifics, saying the serum contains 0.15% retinal and 5% Volufiline (her claims, not verified here), and she shows exactly where she applies it, under the eyes and along the smile lines. The copy repeats her personal result in plain words, which keeps the testimonial tied to one person's experience.
The ad promises a how-to and the page doesn't finish the lesson: the capture shows the How to use accordion empty and the reviews section at zero with a be-the-first prompt. So someone who clicked to learn the right way to use it, or to see if others liked it, finds neither. The ad also has no offer or price cue to give a reason to buy now. If you make an educational testimonial like this, make sure the page carries the same steps (a short clip of the creator near the buy box is the easiest way) and some form of proof before you send traffic.
It opens on concerns the viewer already has, so they know right away whether this is for them.
It reframes the ad as a lesson, which gives even current retinoid users a reason to keep watching.
The specifics and the exact application zones make her claims concrete and easy to picture.
It closes on her result and positions the product as an upgrade to what the viewer already does.
The ad lands on the Vita A Retinal Volume Booster product page, the only ad in the Fluid library sent there, which the persona would call a basic product page. The buy box is tidy: the price and struck-through price sit inside the Add to cart bar, a complete-the-set list sits right under it, and a spec card covers skin type, concerns and key ingredients. The open overview and clinical test accordions add ingredient detail and measured result labels. What's missing is the bridge from the ad: no creator content, an empty How to use accordion in the capture and no reviews yet, so the how-to promise and the testimonial both stop at the click.
Medicube's Vita A Retinal Volume Booster Serum page is a short, plain skincare product page: a buy box with the price inside Add to cart, a Complete the set cross-sell, a spec card, open overview and clinical-test accordions, and an empty reviews block. One Medicube ad in the Fluid library links here, a creator testimonial.
A two-color bar promoting a device line and the store nav with an ambassador link and a routine finder place the serum inside the wider brand.
Infographic, model and comparison thumbnails beside a pack shot, plus the name, subtitle and an Add to cart carrying the sale price, answer what it is and what it costs.
Cross-sell rows with thumbnails, prices and Add buttons answer what pairs with the serum.
Skin type, concerns and key ingredients answer whether it suits your skin.
A product description, ingredient bullets, a Recommended for checklist and a testing footnote explain what the brand says the serum does and who it's for.
Result labels with figures the brand reports, followed by How to use and FAQ accordions that look empty in the capture.
An empty star row and a Be the first prompt show there are no reviews yet.
A subscriber-coupon signup and link columns, including an authenticity guide, close the page.
Read the full breakdown of this page
One of 28 Medicube ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 20, 2026. We record that an ad ran publicly, not how it performed.